At a glance
ClinicalIndex Comparison RecordN/ACompleted· 33 enrolled
Drug / intervention
Bioclean MPS VII +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
BIOCLEAN MPS (Multi-Purpose Solution) VII in Combination With Biofinity Lens: A Two Week Crossover Study
In Brief
A clinical study evaluating Bioclean MPS VII, Aosept Clearcare, and 1 other intervention for Myopia. Completed, enrolled 33 participants across 3 sites.
Detailed Summary
Two week, Open Label, randomized, bilateral, crossover, 1 week of daily wear in each combination (lens / disinfecting cleaning system).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMyopia
CountriesJapan
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartSep 2015
First PostedSep 2015
Primary CompletionOct 2015
Study CompletionJun 2016
TodayJul 2026
First PostedSep 2, 2015
Enrollment StartSep 1, 2015
Primary CompletionOct 1, 2015
Study CompletionJun 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 10.8 years ago
Interventions
Bioclean MPS VIIdevice
PHMB (Polyhexamethylene biguanide) base Disinfecting and Cleaning system
Aosept Clearcaredevice
Hydrogen Peroxide Disinfecting and Cleaning system
comfilcon Adevice
contact lens